Off-resonance saturation as a means of generating contrast with superparamagnetic nanoparticles

Magnetic Resonance in Medicine

Volumn 56, Issue 4, 2006, Pages 726-732

  Zurkiya, Omar ^a   Hu, Xiaoping ^a  

^a Emory University   (United States)

Author keywords

Contrast agent; Iron oxide; Nanoparticles; Off resonance saturation; Superparamagnetic

Indexed keywords

DIFFUSION; FREQUENCY ALLOCATION; IRON OXIDES; NANOPARTICLES; SUPERPARAMAGNETISM;

CONTRAST AGENT; FREQUENCY OFFSETS; MAGNETIZATION TRANSFER; OFF-RESONANCE; PARTICLE CONCENTRATIONS; SUPERPARAMAGNETIC NANOPARTICLES; SUPERPARAMAGNETIC PARTICLES; SUPERPARAMAGNETICS;

RESONANCE;

CONTRAST MEDIUM; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CALCULATION; CHEMICAL EXCHANGE DEPENDENT SATURATION TRANSFER; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; DIFFUSION; FREQUENCY ANALYSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OFF RESONANCE SATURATION; SUPERPARAMAGNETIC NANOPARTICLE; THEORETICAL MODEL;

EID: 33749167851     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21024     Document Type: Article

References (24)

1. Bulte JWM, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004;17:484-499.
2. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001;19:1141-1147.
3. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000;18:410-414.
4. Weissleder R. Target-specific superparamagnetic MR contrast agents. Magn Reson Med 1991;22:209-212.
5. Remsen LG, McCormick CI, Roman-Goldstein S, Nilaver G, Weissleder R, Bogdanov A, Hellstrom KE, Hellstrom I, Kroll RA, Neuwelt EA. MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis. AJNR Am J Neuroradiol 1996;17:411-418.
6. Moore A, Basilion JP, Chiocca EA, Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta 1998;1402:239-249.
7. Bulte JW, Zhang S, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA 1999;96:15256-15261.
8. Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 2003;49:403-408.
9. Seppenwoolde J-H, Viergever MA, Bakker CJG. Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn Reson Med 2003;50:784-790.
10. Coristine AJ, Foster P, Deoini SC, Heyn C, Rutt BK. Positive contrast labelling of SPIO loaded cells in cell samples and spinal cord injury. In: Proceedings of the 12th Annual Meeting of ISMRM, Kyoto, Japan, 2004.
11. Cunningham CH, Arai T, Yang PC, McConnell MV, Pauly JM, Conolly SM. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005;53:999-1005.
12. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000;143:79-87.
13. Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989;10:135-144.
14. Nitin N, LaConte LE, Zurkiya O, Hu X, Bao G. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J Biol Inorg Chem 2004;9:706-712.
15. Vergara A, Paduano L, Vitagliano V, Sartorio R. Mutual diffusion in aqueous solution of poly(ethyleneglycol) samples. Some comments on the effect of chain length and polydispersity. Phys Chem Chem Physics 1999;1:5377-5383.
16. Shen T, Weissleder R, Papisov M, Alexei Bogdanov J, Brady TJ. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 1993;29:599-604.
17. Zimmer C, Wright Jr SC, Engelhardt RT, Johnson GA, Kramm C, Breakefield XO, Weissleder R. Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface. Exp Neurol 1997;143:61-69.
18. Roberts HC, Roberts TP, Ley S, Dillon WP, Brasch RC. Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol 2002;9(Suppl 1):S151-155.
19. Gossuin Y, Roch A, Lo Bue F, Muller RN, Gillis P. Nuclear magnetic relaxation dispersion of ferritin and ferritin-like magnetic particle solutions: a pH-effect study. Magn Reson Med 2001;46:476-481.
20. Gossuin Y, Roch A, Muller RN, Gillis P. Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange. Magn Reson Med 2000;43:237-243.
21. Henkelman RM, Huang X, Xiang QS, Stanisz GJ, Swanson SD, Bronskill MJ. Quantitative interpretation of magnetization transfer. Magn Reson Med 1993;29:759-766.
22. Lutsep HL, Albers GW, DeCrespigny A, Kamat GN, Marks MP, Moseley ME. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 1997;41:574-580.
23. Desprechins B, Stadnik T, Koerts G, Shabana W, Breucq C, Osteaux M. Use of diffusion-weighted MR imaging in differential diagnosis between intracerebral necrotic tumors and cerebral abscesses. AJNR Am J Neuroradiol 1999;20:1252-1257.
24. Sun PZ, van Zijl PC, Zhou J. Optimization of the irradiation power in chemical exchange dependent saturation transfer experiments. J Magn Reson 2005;175:193-200.